Day 3: Monday, May 5, 2014
8:00am – 9:00pm

8:00am - 8:15am

Bonnie Anderson, Board of Directors,
Moment of Silence

8:15am – 9:45am

Disrupt, Innovate, Transform: Is it Time Research Tried it Another Way?

Why are research results becoming increasingly irreproducible, less meaningful, and unaffordable? Is this the consequence of playing it safe, rewarding the status quo and being satisfied with incremental progress?  What if we committed to disruptive approaches that took bold risks and used innovation to upend the status quo.  Would we get different results?

Stephen Friend, MD

Stephen Friend Bio Image  Pat Haugen Bio Image  Susan Fitzpatrcik Bio Image


Dan Sarewitz Bio Image

9:45am – 10:00am


10:00am – 11:00pm

Advanced Seminars:

 Physical Sciences and Oncology Centers—What are we learning?   
What has resulted from an innovative network of trans-disciplinary centers that integrate the physical and biological sciences to better understand cancer across scales?  The premise was that the synergy of large scale and individual initiated research, precompetitive research, and public databases across disciplines would more effectively detect, prevent and treat cancer.  Are they fulfilling the promise?

Speakers: Paul Davies, PhD, Dennis Wirtz, PhD

Paul Davies Bio Image  Denis Wirtz Bio Image

DCIS: What do we know and what do we need to know?
Consensus conference, new research identifying invasive types, recommendations to rethink mammography and treatment practices for DCIS. What do we know about DCIS now and how are we treating DCIS that has made a difference to women? 
Moderator: Judi Hirshfield-Bartek, RN, MS, OSN, Dr. Susan Love Research Foundation.

Thea Tlsty Bio Image  Kim Lyerly Bio Image

Roundtable: DOD Researchers and Era of Hope Scholars Discuss Innovation 
Hear about the type of innovation that is being funded through the DOD Breast Cancer Research Program and the barriers creativity in science face. This will be an inside discussion of what it takes and what it means to be breaking ground in innovative ways in breast cancer research. 
Moderator: Pat Haugen

Jayanta Debnath Bio Image  Stuart Martin  Bio Image  Stephen Johnston  Bio Image
Clinical Trials: Recruiting Patients to Promising Clinical Trials
NBCC is currently partnering on several clinical trials involving PARP inhibitors and CDK 4/6 inhibitors. Hear from some of the clinicians involved in these trials and advocates providing trial design feedback and public education on issues and strategies for assuring participation in meaningful clinical trials. 

Speakers -
 Community Trial Coordinators:

 Liz Frank Bio Image
  Puhalla Shannon Bio Image  Vered Stearns Bio Image

11:00am – 12:00pm Advocate/Speaker Meet-up
These small group conversations are designed to bring together advocates and the Summit presenters for an informal dialogue on top of mind issues. Whether it is a thorny research dilemma or a follow up to a provocative point made in a plenary, these sessions will allow for the kinds of interactions leaders will find stimulating and insightful. 

Speakers: Paul Davies, PhD; Denis Wirtz, PhD; THea Tlsty, PhD; H. Kim Lyerly, MD; Stuart Martin, MD; Jayanta Debnath, MD; Stephen Johnston, MD; Vered Stearns, MD; Stephen Friend, MD, PhD; Susan Fitzpatrick, PhD; Leslie Bernstein, PhD, Shannon Puhalla, MD.  
12:00pm – 1:15pm 

Luncheon - Award Presentation and Summit Summary Remarks

Leslie Bernstein, PhD, City of Hope, will receive the Leadership in Science Award.
Fran Visco will give a summary of this portion of the Leadership Summit. 

Marlene McCarthy, NBCC Board member, Rhode Island Breast Cancer Coalition  

1:20pm – 1:50pm 

Special Report: Targeting Drug-Resistant Metaplastic Cancers 

Metaplastic breast tumors are the most metastatic tumors diagnosed and are resistant to all know therapeutics. Recent work has provided insights into the composition and character of metaplastic breast tumores and, most importantly, potential leads in therapeutic approaches. This work has the potential to provide novel insights into the generation of the lethal behaviors that fuel breast cancer deaths. 


Thea Tlsty Bio Image

Advocacy in Action Program Starts

2:00pm - 3:30pm

Ending Breast Cancer: The Role of Public Policy

Learn about NBCC’s 2014 Legislative and Public Policy Priorities and the key role they play in the Breast Cancer Deadline 2020® strategic plan for knowing how to end breast cancer by January 1, 2020. Hear the strategy we’ll implement to advance the priorities on Tuesday May 6th Capitol Hill Lobby Day.


Fran Visco Bio Image 

3:30pm - 3:45pm Break
3:45pm – 5:00pm Strategy Workshops

Develop state-based strategies by incorporating training for the new grassroots engagement challenges for 2014/15.

5:00pm – 5:15pm Break
5:15pm – 6:00pm State Delegation Meetings

7:00pm – 9:00pm Reception/ Dance
Join us for a dance party to rev up for Lobby Day!

2014 Summit Promo Image Photos

     2014 Summit Page Get Inspired

      Watch President’s 2013 Address

      Get a taste of last year’s Summit

      Learn at NBCC’s Online Center for Advocacy Training

      Women with Balls®: STRIKE! Breast Cancer is back!